Latest News

As the Australian share market grapples with the effects of a cautious budget and external pressures from U.S. economic data, investors are keenly observing opportunities that may arise from recent market fluctuations. In this environment, identifying stocks trading at a discount can offer potential value, particularly when broader economic conditions suggest careful spending and strategic investment decisions.

Even if it's not a huge purchase, we think it was good to see that Matthew Miller, the Co-Chairman of the Board of...

The Australian share market has been experiencing a challenging period, with recent budget announcements and global economic concerns, such as rising U.S. inflation and fluctuating oil prices, impacting investor sentiment. In this environment, identifying promising small-cap stocks can be crucial for portfolio enhancement, as these undiscovered gems often possess growth potential that aligns well with the dynamic market landscape.

The Australian share market is experiencing a downturn following the release of the federal budget and rising inflation in the U.S., with both factors contributing to a cautious trading atmosphere. Despite these challenges, investors are still on the lookout for opportunities, particularly in areas that might offer growth potential amid broader market uncertainties. Penny stocks, though an outdated term, continue to represent smaller or less-established companies that can provide value;...

Doximity (NYSE:DOCS) has partnered with Aledade to plug its HIPAA-compliant Clinical AI Suite, including Scribe and Ask, into Aledade’s EHR overlay platform. The integration targets value-based primary care and independent practices, aiming to streamline documentation and surface clinical insights at the point of care. Doximity has also begun monetizing its AI-driven search product for pharmaceutical marketers, opening a new revenue channel tied to digital promotion budgets. Doximity,...

The analysts covering Editas Medicine, Inc. ( NASDAQ:EDIT ) delivered a dose of negativity to shareholders today, by...

With WaFd on many watchlists, the key question is whether the recent share price reflects a fair deal or if there is still value on the table. At a last close of US$34.59, the stock is down 2.9% over the past week, up 5.7% over the past month, and has returned 21.2% over the past year, which can change how investors think about both upside potential and risk. Recent coverage has focused on WaFd's position in the US regional banking space and how investors are reacting to sector specific...

Why recent LiDAR partnerships matter for Innoviz Technologies (NasdaqCM:INVZ) Recent announcements around InnovizTwo evaluations set the stage for Innoviz Technologies (NasdaqCM:INVZ), including an on-sensor perception software agreement and a separate letter of intent with LOXO for L4 autonomous delivery vehicles. See our latest analysis for Innoviz Technologies. These new LiDAR evaluation agreements come as momentum has picked up in the short term, with 1 day, 7 day and 30 day share price...

Why Uniper’s latest earnings matter for shareholders Uniper (XTRA:UN0) just released first quarter 2026 results, with sales of €17,414 million compared with €21,341 million a year earlier, while net income moved to €335 million from €85 million. Basic earnings per share from continuing operations came in at €0.8 compared with €0.2 a year ago, putting profitability at the center of the current discussion around the stock. See our latest analysis for Uniper. At a share price of €43.75, Uniper’s...

Canadian Tire Corporation (TSX:CTC.A) has attracted fresh attention following recent share price weakness, with the stock down 8% over the past month even as its return over the past three months remains positive. See our latest analysis for Canadian Tire Corporation. Short term momentum has faded, with the share price down 7.6% over the past month after a weaker week, although the 1-year total shareholder return of 19.1% still points to a healthier longer term picture. If this shift in...

It looks like Papa John's International, Inc. ( NASDAQ:PZZA ) is about to go ex-dividend in the next three days. The...

Murphy Oil USA Inc., a subsidiary of Murphy USA, recently completed a private US$500,000,000 senior unsecured notes offering due 2034, guaranteed by Murphy USA and key domestic subsidiaries, to refinance US$300,000,000 of 2027 notes, reduce revolver borrowings, and fund general corporate purposes. This refinancing reshapes Murphy USA’s debt profile and financial flexibility at the same time shareholders approved existing governance arrangements and the board lifted the quarterly dividend to...

Coherent Corp.'s ( NYSE:COHR ) stock was strong after they recently reported robust earnings. We did some analysis and...

LEG Immobilien (XTRA:LEG) has opened Q1 2026 with total revenue of €367.7 million and basic EPS of €1.03, giving investors a fresh datapoint after a year of very large earnings swings that were heavily influenced by one off items. The company has seen quarterly revenue move from €515.9 million in Q4 2024 to a range between €351.4 million and €468.7 million across 2025, while basic EPS shifted between €0.81 and €9.08 over the same period. This underscores just how volatile the income line has...

Nidec (TSE:6594) is under increased scrutiny after confirming accounting misconduct and potential quality issues. An Extraordinary General Meeting and board changes are planned as the company works through governance and reporting challenges. See our latest analysis for Nidec. The recent disclosures around accounting and potential quality issues sit against a sharp short‑term rebound, with a 1‑month share price return of 21.20% and year‑to‑date share price return of 28.44%. However, the...

Sumitomo Mitsui Financial Group (TSE:8316) has just wrapped up FY 2026 with fourth quarter revenue of ¥1.5 trillion and basic EPS of ¥49.30, while over the trailing twelve months revenue reached ¥6.1 trillion and EPS came in at ¥411.97 as earnings expanded 231.1% and net profit margin moved from 14.6% to 26.1%. Over recent periods, revenue has shifted from ¥1.3 trillion in FY 2025 Q3 to ¥1.5 trillion in FY 2026 Q4, with quarterly EPS ranging between ¥97.46 and ¥144.69 before landing at...

Carl Zeiss Meditec (XTRA:AFX) has just posted its Q2 2026 numbers, with revenue at €524.0 million and basic EPS of €0.22, setting the tone for how investors might read the latest quarter. Over recent periods, revenue has moved between €560.0 million in Q2 2025 and €524.0 million in Q2 2026, while EPS has ranged from €0.52 in Q2 2025 to €0.22 in the latest quarter. This gives a clearer view of how the top line and per share earnings have tracked into this result. With trailing net profit...

Amtech Systems, Inc. ( NASDAQ:ASYS ) announced a healthy earnings result recently, and the market rewarded it with a...

As global markets shift focus back to economic fundamentals amid geopolitical tensions, Canadian investors are keeping a close eye on emerging opportunities. Penny stocks, while often seen as remnants of an earlier trading era, continue to attract attention for their potential value in the market. These smaller or newer companies can offer significant growth prospects when supported by strong financials, and today we explore three such penny stocks that stand out for their balance sheet...

Tarsus Pharmaceuticals, Inc. recently reported first-quarter 2026 results, with revenue of US$162.05 million versus US$78.34 million a year earlier and a reduced net loss of US$6.97 million, and it also participated in the Bank of America Global Healthcare Conference 2026 in Las Vegas. The combination of sharply higher sales and a smaller loss suggests improving operating leverage and may influence how investors view the durability of its business model. We’ll now examine how this stronger...

What Okinawa Cellular Telephone’s buyback announcement means for shareholders Okinawa Cellular Telephone (TSE:9436) has authorized a share repurchase program of up to 1,700,000 shares, or 1.85% of its issued share capital, capped at ¥5,000 million through April 16, 2027. The Board describes the buyback as a way to return profits to shareholders and improve capital efficiency. This puts the focus on how reduced share count and capital allocation priorities might affect your long term exposure...

Caris Life Sciences (CAI) is drawing fresh attention after publishing new tumor mutational burden data, rolling out MI Clarity for breast cancer, securing MolDX approval for ChromoSeq, and reporting detailed first quarter 2026 results. See our latest analysis for Caris Life Sciences. The latest run of product launches and clinical data has not yet translated into positive share price momentum, with Caris Life Sciences' share price return falling 12.35% over the past day and 45.55% year to...

Weis Markets, Inc. has reported past first-quarter 2026 results, with sales rising to US$1,251.72 million and revenue to US$1,255.91 million, alongside net income of US$27.85 million. Earnings strength was also reflected in basic earnings per share from continuing operations, which increased to US$1.13 from US$0.73 a year earlier. Next, we will examine how this earnings improvement, particularly the higher net income, shapes Weis Markets’ broader investment narrative. The future of work is...

Sphere Entertainment Co. reported past first-quarter 2026 results with sales of US$386.41 million versus US$280.57 million a year earlier, while net loss narrowed to US$1.59 million from US$81.95 million and loss per share from continuing operations improved to US$0.04 from US$2.27. Despite this operational improvement, the company now faces a tougher backdrop as record-low consumer sentiment and rising household cost pressures weigh on demand for discretionary leisure experiences. With...